ATP LIFE SCIENCE VENTURES, L.P.

NEW YORK, NY How do I update this listing?

ATP Life Science Ventures is based out of New York. Their last reported 13F filing for Q1 2021 included $898,305,000 in managed 13F securities and a top 10 holdings concentration of 100.0%. ATP Life Science Ventures's largest holding is Stoke Therapeutics Inc with shares held of 17,161,713. Whalewisdom has at least 6 13F filings, 9 13D filings, 2 13G filings, and 4 Form 4 filings

Download 13F Summary Create Alert

03/31/2021

Top Buys

  • Name% Change

03/31/2021

Top Sells

  • Name% Change

03/31/2021

13F Activity

  • Market Value $898.305 Million
  • Prior Market Value $1.295 Billion
  • New Purchases0 stocks
  • Additional Purchases0 stocks
  • Sold out of0 stocks
  • Reduced holdings in0 stocks
  • Top 10 Holdings % 100.00 %
  • Turnover % [1]:%
  • Turnover Alt % [2]: %
  • Time Held Top20:3.67 quarters
  • Time Held Top10:3.67 quarters
  • Time Held All:3.67 quarters

[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.

[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.

03/31/2021

13F Sector Allocation Over Time

Portfolio Performance

Top 20 equal-weighted holdings. Performance numbers calculated through 2021-05-17

Performance for Q1 2021: -15.04%
Performance Last 4 Quarters: 46.6%
Performance Metrics
Stats are not available for the latest quarter

Refresh Advanced Export Download CSV Download Excel (.xlsx) Download TSV
Filter by:

Security Types:

Refresh
*Shares are split adjusted
This lets you look at individual sub managers or subsidiaries within the 13F filing.

13F Managers

Subsidiaries/Managers included in latest 13F
Name
ATP III GP, Ltd.

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Elevate your investments